Related Experiment Videos
Sexual functioning in breast cancer survivors
C L Thors1, J A Broeckel, P B Jacobsen
1Psychosocial and Palliative Care Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Cancer Control : Journal of the Moffitt Cancer Center
|October 2, 2001
Summary
Sexual dysfunction is a common and distressing symptom for breast cancer survivors. Chemotherapy significantly increases the risk, while surgery type and tamoxifen show less impact on sexual health outcomes.
Area of Science:
- Oncology
- Sexual Medicine
- Survivorship Care
Background:
- Sexual dysfunction is a prevalent and distressing symptom in breast cancer survivors.
- Understanding the impact of cancer treatments on sexual health is crucial for improving quality of life.
Purpose of the Study:
- To review the existing literature on sexual functioning in breast cancer survivors.
- To examine the prevalence, nature, and treatment of sexual difficulties post-breast cancer therapy.
Main Methods:
- Systematic review of studies investigating sexual functioning in breast cancer survivors.
- Analysis of reported prevalence rates, treatment-related factors, and management strategies.
Main Results:
- Prevalence of sexual problems varies widely, influenced by study methodology and patient characteristics.
- Chemotherapy is strongly associated with increased risk of sexual dysfunction.
- Limited evidence links surgical approach (lumpectomy vs. mastectomy) or tamoxifen to sexual outcomes.
Conclusions:
- Sexual dysfunction can be a persistent side effect of breast cancer treatment.
- Oncology professionals should proactively address sexual health concerns with patients.
- Comprehensive assessment and patient education are vital for managing sexual difficulties.